Trial intelligence / Profile preview

Chondron in Patients With Cartilage Defects in Their Ankle

NCT02537067Phase 3Terminated

Sponsor
Sewon Cellontech Co., Ltd.
Start
Jan 2010
Primary completion
May 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of autologous cultured chondrocytes in Osteochondral lesion of the talus (OLT), sponsored by Sewon Cellontech Co., Ltd.. Started Jan 2010; status: terminated.

02

Drugs

autologous cultured chondrocytes
03

Conditions

Osteochondral lesion of the talus (OLT)

Beyond the preview

Go deeper on NCT02537067.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02537067.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call